Michael Martin Breen, CEO of GT Biopharma GTBP, has filed 2 purchases and 0 sales on the open market. The latest trade was on 25/09/04.

MB

MB

Michael Martin Breen

CEO and Director

Company

GT Biopharma GTBP

First filing

23/02/01

Trades

11 trades

Buys / sales

2 / 0

12-month net buying

No record

Last trade

25/09/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Prairie OperatingPROP	Open-market buy	23/05/03	23/05/05	916,112 sh	$0.11	$100,772.32	+9161.1%
GT BiopharmaGTBP	Open-market buy	23/04/11	23/04/11	50,000 sh	$0.50	$25,000	+8.2%